You should visit your health care provider regularly, even if you feel healthy. The purpose of these visits is to:
- Screen for medical issues
- Assess your risk for future medical problems
- Encourage a healthy lifestyle
- Update vaccinations
- Help you get to know your provider in case of an illness
Even if you feel fine, you should still see your provider for regular checkups. These visits can help you avoid problems in the future. For example, the only way to find out if you have high blood pressure is to have it checked regularly. High blood sugar and high cholesterol level also may not have any symptoms in the early stages. Simple blood tests can check for these conditions.
There are specific times when you should see your provider. Below are screening guidelines for men ages 40 to 64.
BLOOD PRESSURE SCREENING
- Have your blood pressure checked at least once every 2 years. If the top number (systolic number) is from 120 to 139 mm Hg, or the bottom number (diastolic number) is from 80 to 89 mm Hg, you should have it checked every year.
- If the top number is 130 or greater or the bottom number is 80 or greater, schedule an appointment with your provider to learn how you can reduce your blood pressure.
- If you have diabetes, heart disease, kidney problems, or certain other conditions, you may need to have your blood pressure checked more often, but still at least once a year.
- Watch for blood pressure screenings in your area. Ask your provider if you can stop in to have your blood pressure checked.
CHOLESTEROL SCREENING AND HEART DISEASE PREVENTION
- Recommended starting age for cholesterol screening is age 35 for men with no known risk factors for coronary heart disease.
- Once cholesterol screening has started, your cholesterol should be checked every 5 years.
- Repeat testing sooner than needed if changes occur in lifestyle (including weight gain and diet).
- If you have a high cholesterol level, diabetes, heart disease, kidney problems, or certain other conditions, you may need to be checked more often.
COLORECTAL CANCER SCREENING
If you are under age 45, talk to your provider about getting screened. You may need to be screened if you have a strong family history of colon cancer or polyps. Screening may also be considered if you have risk factors such as a history of inflammatory bowel disease or polyps.
If you are age 45 to 75, you should be screened for colorectal cancer. There are several screening tests available:
- A stool-based fecal occult blood (gFOBT) or fecal immunochemical test (FIT) every year
- A stool sDNA test every 1 to 3 years
- Flexible sigmoidoscopy every 5 years or every 10 years with stool testing FIT done every year
- CT colonography (virtual colonoscopy) every 5 years
- Colonoscopy every 10 years
You may need a colonoscopy more often if you have risk factors for colorectal cancer, such as:
- Ulcerative colitis
- A personal or family history of colorectal cancer
- A history of growths called adenomatous polyps
- Go to the dentist once or twice every year for an exam and cleaning. Your dentist will evaluate if you have a need for more frequent visits.
- If you are over age 44, you should be screened every 3 years.
- Having a BMI over 25 means that you are overweight. If you are overweight, you should be screened starting at age 35. Asian Americans should be screened if their BMI is greater than 23.
- If your blood pressure is above 130/80 mm Hg, or you have other risk factors for diabetes, your provider may test your blood sugar level for diabetes.
- Have an eye exam every 2 to 4 years ages 40 to 54 and every 1 to 3 years ages 55 to 64. Your provider may recommend more frequent eye exams if you have vision problems or glaucoma risk.
- Have an eye exam at least every year if you have diabetes.
- You should get a flu shot every year.
- Ask your provider if you should get a vaccine to reduce your risk of pneumococcal infection (causes a type of pneumonia).
- You should have a tetanus-diphtheria and acellular pertussis (Tap) vaccine once as part of your tetanus-diphtheria vaccines if you did not receive it previously as an adolescent. You should have a tetanus-diphtheria booster every 10 years.
- You may get a shingles or herpes zoster vaccination at or after age 50.
- Your provider may recommend other immunizations if you are at high risk for certain conditions.
INFECTIOUS DISEASE SCREENING
- The US Preventive Services Task Force recommends screening for hepatitis C.
- Depending on your lifestyle and medical history, you may need to be screened for infections such as syphilis, chlamydia, and HIV, as well as other infections.
LUNG CANCER SCREENING
You should have an annual screening for lung cancer with low-dose computed tomography (LDCT) if:
- You are age 5 to to 80 years AND
- You have a 20 pack-year smoking history AND
- You currently smoke or have quit within the past 15 years
- If you are age 50 to 70 and have risk factors for osteoporosis, you should discuss screening with your provider.
- Risk factors can include long-term steroid use, low body weight, smoking, heavy alcohol use, having a fracture after age 50, or a family history of osteoporosis.
- Your blood pressure should be checked at least every year.
- Your provider may recommend checking your cholesterol every 5 years if you have risk factors for coronary heart disease.
- Your height, weight, and body mass index (BMI) should be checked at every exam.
During your exam, your provider may ask you about:
- Diet and exercise
- Alcohol and tobacco use
- Safety, such as use of seat belts and smoke detectors
PROSTATE CANCER SCREENING
If you're 55 through 69 years old, before having the test, talk to your provider about the pros and cons of having a PSA test. Ask about:
- Whether screening decreases your chance of dying from prostate cancer.
- Whether there is any harm from prostate cancer screening, such as side effects from testing or overtreatment of cancer when discovered.
- Whether you have a higher risk of prostate cancer than others.
If you are age 55 or younger, screening is not generally recommended. You should talk with your provider about if you have a higher risk for prostate cancer. Risk factors include:
- Having a family history of prostate cancer (especially a brother or father)
- Being African American
- If you choose to be tested, the PSA blood test is repeated over time (yearly or less often), though the best frequency is not known.
- Prostate examinations are no longer routinely done on men with no symptoms.
- Your provider may check your skin for signs of skin cancer, especially if you're at high risk. People at high risk include those who have had skin cancer before, have close relatives with skin cancer, or have a weakened immune system.
- The US Preventive Services Task Force (USPSTF) now recommends against performing testicular self-exams. Doing testicular self-exams has been shown to have little to no benefit.
Health maintenance visit - men - ages 40 to 64; Physical exam - men - ages 40 to 64; Yearly exam - men - ages 40 to 64; Checkup - men - ages 40 to 64; Men's health - ages 40 to 64; Preventive care - men - ages 40 to 64
Advisory Committee on Immunization Practices. Recommended immunization schedule for adults aged 19 years or older, United States, 2020. www.cdc.gov/vaccines/schedules/index.html. Updated February 3, 2020. Accessed April 18, 2020.
American Academy of Ophthalmology website. Clinical statement: frequency of ocular examinations - 2015. www.aao.org/clinical-statement/frequency-of-ocular-examinations. Updated March 2015. Accessed April 18, 2020.
American Dental Association website. Your top 9 questions about going to the dentist - answered. www.mouthhealthy.org/en/dental-care-concerns/questions-about-going-to-the-dentist. Accessed April 18, 2020.
American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes - 2020. Diabetes Care. 2020;43(Suppl 1):S14–S31. PMID: 31862745 pubmed.ncbi.nlm.nih.gov/31862745/.
Atkins D, Barton M. The periodic health examination. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 12.
Cosman F, de Beur SJ, LeBoff MS, et al. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359-2381. PMID: 25182228 pubmed.ncbi.nlm.nih.gov/25182228/.
Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [published correction appears in J Am Coll Cardiol. 2019 Jun 25;73(24):3237-3241]. J Am Coll Cardiol. 2019;73(24):e285-e350. PMID: 30423393 pubmed.ncbi.nlm.nih.gov/30423393/.
Mazzone PJ, Silvestri GA, Patel S, et al. Screening for lung cancer: CHEST Guideline and Expert Panel Report. Chest. 2018;153(4):954-985. PMID: 29374513 pubmed.ncbi.nlm.nih.gov/29374513/.
Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(12):3754-3832. PMID: 25355838 pubmed.ncbi.nlm.nih.gov/25355838/.
Moyer VA; US Preventive Services Task Force. Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(5):330-338. PMID: 24378917 pubmed.ncbi.nlm.nih.gov/24378917/.
Ridker PM, Libby P, Buring JE. Risk markers and the primary prevention of cardiovascular disease. In: Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia, PA: Elsevier; 2019:chap 45.
Siu AL; US Preventive Services Task Force. Screening for high blood pressure in adults: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(10):778-786. PMID: 26458123 pubmed.ncbi.nlm.nih.gov/26458123/.
US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for skin cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;316(4):429-435. PMID: 27458948 pubmed.ncbi.nlm.nih.gov/27458948/.
US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, et al. Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement. JAMA. 2021;326(8):736-743. PMID: 34427594 pubmed.ncbi.nlm.nih.gov/34427594/.
US Preventive Services Task Force website. Final recommendation statement. Colorectal cancer screening. www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening. Published May 18, 2021. Accessed June 29, 2021.
US Preventive Services Task Force website. Final recommendation statement. Colorectal cancer screening. www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening. Published June 15, 2016. Accessed April 18, 2020.
US Preventive Services Task Force website. Final recommendation statement. Hepatitis C virus infection in adolescents and adults: screening. www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening. Published March 2, 2020. Accessed April 19, 2020.
US Preventive Services Task Force website. Final recommendation statement. Prostate cancer: screening. www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening. Published May 8, 2018. Accessed April 18, 2020.
US Preventive Services Task Force website. Final recommendation statement. Testicular cancer: screening. www.uspreventiveservicestaskforce.org/uspstf/recommendation/testicular-cancer-screening. Published April 15, 2011. Accessed April 19, 2020.
Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [published correction appears in J Am Coll Cardiol. 2018 May 15;71(19):2275-2279]. J Am Coll Cardiol. 2018;71(19):e127-e248. PMID: 29146535 pubmed.ncbi.nlm.nih.gov/29146535/.
Review Date 4/19/2020
Updated by: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team. Editorial update 09/03/2021.